 |
|
Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea
Min-Suk Yang, Ju-Young Kim, Min-Gyu Kang, Suh-Young Lee, Jae-Woo Jung, Sang-Heon Cho, Kyung-Up Min, Hye-Ryun Kang
Korean J Intern Med. 2019;34(1):195-201. Published online 2018 Feb 23 DOI: https://doi.org/10.3904/kjim.2015.365
|
|
Citations to this article as recorded by
 Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond HLA-B*15:02
Stephani L. Stancil, Tracy Sandritter, Jeffrey R. Strawn
Journal of Child and Adolescent Psychopharmacology.2024; 34(1): 61. CrossRef The Application of Knowledge-Based Clinical Decision Support Systems to Detect Antibiotic Allergy
Nayoung Han, Ock Hee Oh, John Oh, Yoomi Kim, Younghee Lee, Won Chul Cha, Yun Mi Yu
Antibiotics.2024; 13(3): 244. CrossRef Risk-conferringHLAvariants in an epilepsy cohort: benefits of multifaceted use of whole genome sequencing in clinical practice
Angeliki Vakrinou, Ravishankara Bellampalli, Medine I Gulcebi, Helena Martins Custodio, Genomics England Research Consortium, Simona Balestrini, Sanjay M Sisodiya
Journal of Neurology, Neurosurgery & Psychiatry.2023; 94(11): 887. CrossRef Advances in Our Understanding of the Interaction of Drugs with T-cells: Implications for the Discovery of Biomarkers in Severe Cutaneous Drug Reactions
Olivia Araceli Hernandez-Jaimes, Diana Valeria Cazares-Olvera, James Line, Mario Adan Moreno-Eutimio, Carlos Zepactonal Gómez-Castro, Dean J. Naisbitt, José Luis Castrejón-Flores
Chemical Research in Toxicology.2022; 35(7): 1162. CrossRef Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens–Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN
Michele L. Ramien, Danny Mansour, Neil H. Shear
Pediatric Drugs.2022; 24(4): 307. CrossRef Costs Associated with Adverse Drug Reactions Among HIV/TB Patients in Thailand
Onwipa Rochanathimoke, Pramote Tragulpiankit, Saowalak Turongkaravee, Jiraphun Jittikoon, Wanvisa Udomsinprasert, Usa Chaikledkeaw
ClinicoEconomics and Outcomes Research.2022; Volume 14: 587. CrossRef Human Leukocyte Antigen Gene Testing and Carbamazepine-Induced Toxic Epidermal Necrolysis: A Study of Pediatric Practice
Jessica M.S. Asgarpour, Lauren M. Lam, Tina K. Vogel, Helly R. Goez, Loretta Fiorillo
Journal of Cutaneous Medicine and Surgery.2021; 25(1): 25. CrossRef A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea
Dong Yoon Kang, James Yun, Suh-Young Lee, Young-Il Koh, Da Woon Sim, Sujeong Kim, Young Hee Nam, Jung-Won Park, Sae Hoon Kim, Young-Min Ye, Hye-Kyung Park, Min-Hye Kim, Young-Koo Jee, Jae-Woo Jung, Min-Suk Yang, Sang-Heon Kim, Jun Kyu Lee, Cheol-Woo Kim,
The Journal of Allergy and Clinical Immunology: In Practice.2021; 9(2): 929. CrossRef New patterns of cutaneous drug eruptions
Robert T. Spaulding, Cindy E. Owen, Jeffrey P. Callen
Clinics in Dermatology.2021; 39(2): 233. CrossRef Allopurinol-Induced Severe Cutaneous Adverse Drug Reactions: An Analysis of Spontaneous Reports in Malaysia (2000–2018)
Sing Chet Lee, Wee Kee Wo, Hee Sheong Yeoh, Norleen Mohamed Ali, Vidhya Hariraj
Therapeutic Innovation & Regulatory Science.2021; 55(3): 514. CrossRef Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients
Dyah Aryani Perwitasari, Sri Awalia Febriana, Ratna Septi Tristiana
Patient Preference and Adherence.2021; Volume 15: 329. CrossRef Clinical Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Severe Ocular Complications in South Korea
Mee Kum Kim, Kyung Chul Yoon, Sook Hyun Yoon, Kyoung Yul Seo
Frontiers in Medicine.2021;[Epub] CrossRef Cost implications of adverse drug event-related emergency department visits – a multicenter study in South Korea
Min-Sun Lee, Ju-Yeun Lee, Min-Gyu Kang, Jae-Woo Jung, Hye-Kyung Park, Hye-Kyung Park, Sang-Heon Kim, Eui-Kyung Lee
Expert Review of Pharmacoeconomics & Outcomes Research.2020; 20(1): 139. CrossRef Allopurinol‐induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia
Rema Panickar, Wee Kee Wo, Norleen M. Ali, Min Moon Tang, G. R. Letchuman Ramanathan, Adeeba Kamarulzaman, Zoriah Aziz
Pharmacoepidemiology and Drug Safety.2020; 29(10): 1254. CrossRef Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China
Fanping Yang, Zihua Chen, Sheng-an Chen, Qinyuan Zhu, Lanting Wang, Hao Xiong, Haijun Fu, Xiaoqun Luo
European Journal of Dermatology.2020; 30(1): 24. CrossRef Efficacy of the HLA-B∗58:01 Screening Test in Preventing Allopurinol-Induced Severe Cutaneous Adverse Reactions in Patients with Chronic Renal Insufficiency—A Prospective Study
Heung-Woo Park, Dong Ki Kim, Sae-Hoon Kim, Sejoong Kim, Dong-Wan Chae, Min-Suk Yang, Yun Kyu Oh, Jung Pyo Lee, Jae-Woo Jung, Jungho Shin, Jin Ho Hwang, Min-Gyu Kang, Sun Moon Kim, Soon Kil Kwon, Hye-Young Kim, Min-Hye Kim, Seung-Jung Kim, Dong-Ryeol Ryu,
The Journal of Allergy and Clinical Immunology: In Practice.2019; 7(4): 1271. CrossRef Cost of managing severe cutaneous adverse drug reactions to first‐line tuberculosis therapy in South Africa
Lauren K. Knight, Rannakoe J. Lehloenya, Edina Sinanovic, Anil Pooran
Tropical Medicine & International Health.2019; 24(8): 994. CrossRef Recent developments and highlights in drug hypersensitivity
Cristobalina Mayorga, Tahia D. Fernandez, Maria Isabel Montañez, Esther Moreno, María José Torres
Allergy.2019; 74(12): 2368. CrossRef
|